TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Skin Medications, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Skin Medications technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Skin Medications

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Industry Landscape Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Skin Medications industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Skin Medications industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Skin Medications industry

Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAApr 10, 2025BRULIE
Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIAMar 27, 2025ARLA FOODS AMBA
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSFeb 1, 2025TEVA PHARMACEUTICALS
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSJan 31, 2025MAIWALD
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYJan 24, 2025DEHMEL & BETTENHAUSEN PATENTANWALTE PARTMBB
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJan 23, 2025SECERNA
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 7, 2024BRAND MURRAY FULLER
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALSNov 6, 2024BOULT WADE TENNANT
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 5, 2024BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB
Pharmaceutical Compositions Of Roflumilast In Aqueous Blends Of Water-Miscible, Pharmaceutically Acceptable SolventsARCUTISAug 13, 2024TEVA PHARMACEUTICALS

To stay ahead in the competitive Skin Medications industry, companies are constantly innovating. Here are the top patents facing oppositions in the Skin Medications industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGY7
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY7
Jun 19, 2019Composition Comprising Hyaluronic Acid And MepivacaineTEOXANE3
Jul 10, 2024Mixture Of Non-Digestible Oligosaccharides For Stimulating The Immune SystemNUTRICIA3
May 1, 2024Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALS2
Sep 13, 2023Lipopeptide Compositions And Related MethodsCUBIST PHARMACEUTICALS2
Jan 26, 2022Dosing Regimen For A Selective S1P1 Receptor AgonistACTELION PHARMACEUTICALS2
Nov 15, 2023Fc Riib-Specific Fc AntibodyCHUGAI SEIYAKU KABUSHIKI KAISHA1
Dec 13, 2017Anti-Inflammatory Effect Of Microfibrillated CelluloseUPM KYMMENE1
Nov 8, 2017Use Of Il-33 Antagonists To Treat Fibrotic DiseaseMERCK SHARP & DOHME1